Kirkland & Ellis advises GTCR on its US$627 million acquisition of Surmodics, with Latham & Watkins advising Oak Hill Advisors and other lenders on the financing.
Surmodics acted as the acquirer in this Acquisition transaction.
The acquisition targeted assets operating in the Healthcare sector.
The transaction was announced on 29 May 2024 with a reported value of 6270000000.0.
Generated by AI, original source from - Data is in progress
Surmodics, Inc. advisor
Firm name is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises GTCR on its US$627 million acquisition of Surmodics, with Latham & Watkins advising Oak Hill Advisors and other lenders on the financing. | The Sponsor - The Sponsor
